KPV
Sourcing GuideSourcing KPV from research-grade vendors requires the QC framework that governs any peptide procurement: certificate of analysis review, lot-specific verification, third-party laboratory issuance, and — critically — endotoxin testing for injectable material. The C-terminal tripeptide of α-melanocyte-stimulating hormone — anti-inflammatory and antimicrobial without α-MSH's pigmentation effects. The three-tier vendor market (pharmaceutical-grade compounded, reputable research-grade, grey-market) is described below.
Key Takeaways
Procurement lens: KPV sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching 342 Da. Mechanism: Suppresses NF-κB activation and IL-1β release. Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days. Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger). Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.
For procurement of KPV, the relevant QC framework covers analytical purity (HPLC), structural identity (mass spec), microbiological safety (endotoxin), and stoichiometric correctness where applicable. Suppresses NF-κB activation and IL-1β release. Stabilises mast cells. Antimicrobial against C. albicans and S. aureus. Acts on gut mucosa to reduce inflammation in IBD models. Does not engage melanocortin receptors strongly, avoiding tanning effects. The subsections below address each QC layer and the vendor-tier landscape.
HPLC purity and analytical identity
Minimum acceptable HPLC purity for KPV is ≥98% in research-grade material. Mass spec confirmation should show the characteristic m/z of 342 (M+H)+. Contaminant peaks above 1% in the HPLC trace warrant quantification on the COA and — ideally — structural identification of the major impurities.
Reconstitution and storage protocols
KPV is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.
COA evaluation and red flags
Acceptable KPV certificates of analysis specify: (1) lot number matching the vial, (2) HPLC purity with chromatographic trace, (3) mass spec confirmation, (4) endotoxin testing for SubQ-route use, and (5) issuance from an accredited third-party laboratory. Template COAs that cannot be traced to a specific lot, COAs missing endotoxin data for injectable material, and COAs issued by the vendor's own laboratory rather than a third party are all sourcing red flags.
For users targeting mass spectrometry verification, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
Sourcing KPV for regulatory sourcing use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
Pharmaceutical-grade compounded KPV is the lowest-risk sourcing path for hplc purity use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
For users targeting cold chain, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 200-500 mcg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 120-500 mcg | 4–6 weeks initial cycle |
| Sourcing Guide focus | SubQ | 200-500 mcg | 1-2x daily SubQ or oral |
| Maintenance phase | SubQ | 140-500 mcg | Ongoing with periodic pauses |
Dose timing for KPV is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
KPV stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.
- KPV + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with KPV's mechanism in sourcing / quality / procurement protocols.
- KPV + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with KPV's mechanism in sourcing / quality / procurement protocols.
- KPV + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with KPV's mechanism in sourcing / quality / procurement protocols.
- KPV + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with KPV's mechanism in sourcing / quality / procurement protocols.
Excellent tolerability. No pigmentation effects.
Lens-specific safety considerations for sourcing / quality / procurement use of KPV: Excellent tolerability. No pigmentation effects. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| KPV | α-MSH-derived anti-inflammatory tripeptide | Short (minutes) | Sourcing Guide |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
Visual quality inspection?
Storage protocol?
Vendor red flags?
Pharmaceutical-grade versus research-grade?
What is the mechanism of action of KPV?
What route should I use for KPV?
Start a KPV Protocol
Alukard provides GMP-certified physician-supervised sourcing with GMP-certified KPV and Pharmaceutical-grade compounds with full COA documentation.
Get ProtocolQuick Facts
- Molecular weight
- 342 Da
- Sequence length
- 3 aa
- Half-life
- Short (minutes)
- WADA
- Not on prohibited list
- FDA
- Unapproved
- Research
- Preclinical + small clinical series
Stack Partners
All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for KPV unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Sourcing / Quality / Procurement Protocol for KPV
Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.
HIPAA Compliant · GMP Certified · Physician Supervised